Skip to content

Clinical effect of the P-CAB administration time on amoxicillin dual regimen in the treatment of Helicobacter pylori

Clinical effect of the P-CAB administration time on amoxicillin dual regimen in the treatment of Helicobacter pylori

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084403
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

P-CAB taken after meals:Amoxicillin-vonoprazan dual therapy
P-CAB taken before meals:Amoxicillin-vonoprazan dual therapy

Sponsors

Changzhou Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1: Age 18~70 years old, male or female 2: No antibiotics, bismuth, or H2 receptor antagonists used in the past four weeks, History of PPI or P-CAB applications; 3: 13C urea breath test positive or gastroscopy confirmed Helicobacter pylori infection 4: Consent to primary treatment for HP eradication therapy and be willing to cooperate with doctors to conduct follow-up investigation of eradication efficacy.

Exclusion criteria

Exclusion criteria: 1: Severe heart, liver and kidney function damage 2: Pregnant or lactating women 3: Previous history of H. pylori therapy,History of upper gastrointestinal surgery, history of gastric malignancy, history of liver and kidney damage, history of pyloric stenosis, pregnancy. 4: Participation in other drug studies within 3 months ; 5: Taking non-steroidal anti-inflammatory drugs or alcohol abuse 6: Patients who are allergic to either drug of the dual regimen

Design outcomes

Primary

MeasureTime frame
Eradication rate;

Secondary

MeasureTime frame
Adverse reaction;compliance;

Countries

China

Contacts

Public ContactXiaoyong Wang

Changzhou Second People's Hospital

wxy20009@126.com+86 137 7505 1593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026